Cosmos Health Financials
COSM Stock | USD 0.80 0.01 1.23% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 0.96 | 1.5051 |
|
|
Investors should never underestimate Cosmos Health's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Cosmos Health's cash flow, debt, and profitability to make informed and accurate decisions about investing in Cosmos Health.
Net Income |
|
Cosmos | Select Account or Indicator |
Understanding current and past Cosmos Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cosmos Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Cosmos Health's assets may result in an increase in income on the income statement.
Cosmos Health Stock Summary
Cosmos Health competes with Lifecore Biomedical, Shionogi, Sunshine Biopharma, China SXT, and Shuttle Pharmaceuticals. Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. Cosmos Holdings Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois. Cosmos Holdings operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US2214132068 |
CUSIP | 221413305 221413206 |
Location | Greece |
Business Address | 141 West Jackson |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.cosmosholdingsinc.com |
Phone | 312 536 3102 |
Currency | USD - US Dollar |
Cosmos Health Key Financial Ratios
Return On Equity | -0.57 | ||||
Profit Margin | (0.38) % | ||||
Operating Margin | (0.19) % | ||||
Price To Sales | 0.33 X | ||||
Revenue | 53.38 M |
Cosmos Health Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Accounts Payable | 8.6M | 12.0M | 12.1M | 10.1M | 11.9M | 12.5M | |
Total Liab | 30.3M | 48.0M | 45.0M | 28.4M | 30.0M | 16.8M | |
Common Stock | 13.2K | 13.5K | 17.5K | 10.6K | 9.5K | 9.1K | |
Total Assets | 23.9M | 43.8M | 49.4M | 68.0M | 66.0M | 69.3M | |
Other Current Liab | 581.5K | 2.0M | 1.3M | 3.2M | 3.5M | 3.6M | |
Net Debt | 19.2M | 31.4M | 26.8M | (8.7M) | 7.4M | 7.6M | |
Cash | 38.5K | 628.4K | 286.5K | 20.7M | 3.8M | 2.8M | |
Total Current Assets | 21.2M | 40.8M | 40.9M | 56.0M | 36.6M | 18.4M | |
Retained Earnings | (19.6M) | (18.8M) | (34.3M) | (66.2M) | (91.6M) | (87.1M) | |
Net Tangible Assets | (3.6M) | (6.7M) | (4.4M) | 3.9M | 3.5M | 3.7M | |
Other Assets | 625.4K | 538.9K | 900.3K | 6.0M | 6.9M | 7.3M | |
Other Current Assets | 665.5K | 9.7M | 1.0M | 9.1M | 6.3M | 3.8M | |
Short Long Term Debt | 18.7M | 20.7M | 13.3M | 8.0M | 8.2M | 9.8M | |
Short Term Debt | 18.9M | 20.0M | 13.6M | 8.3M | 9.6M | 9.9M | |
Net Receivables | 9.3M | 26.9M | 30.1M | 22.8M | 19.8M | 14.2M | |
Inventory | 3.5M | 3.3M | 3.1M | 3.5M | 4.8M | 3.1M | |
Intangible Assets | 214.0K | 180.8K | 443.5K | 657.2K | 7.6M | 4.6M | |
Net Invested Capital | 12.2M | 27.3M | 30.4M | 50.2M | 47.3M | 29.3M | |
Net Working Capital | (7.1M) | 6.0M | 11.0M | 34.3M | 12.3M | 7.6M |
Cosmos Health Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 1.7M | 2.8M | 3.6M | 4.0M | 866.5K | 1.6M | |
Operating Income | (21.9K) | 2.7M | (4.5M) | (7.5M) | (21.8M) | (20.7M) | |
Ebit | (21.9K) | 2.8M | (4.5M) | (9.1M) | (8.2M) | (7.8M) | |
Ebitda | 372.7K | 3.2M | (4.1M) | (8.9M) | (8.0M) | (7.6M) | |
Income Before Tax | (3.1M) | 1.2M | (7.8M) | (13.1M) | (18.5M) | (17.6M) | |
Net Income | (3.3M) | 820.8K | (8.0M) | (13.8M) | (18.5M) | (17.6M) | |
Income Tax Expense | 182.8K | 377.5K | 114.0K | 775.1K | 891.3K | 935.9K | |
Total Revenue | 39.7M | 55.4M | 56.2M | 50.3M | 53.4M | 33.8M | |
Gross Profit | 3.7M | 8.1M | 8.3M | 6.0M | 4.3M | 4.4M | |
Cost Of Revenue | 36.0M | 47.3M | 47.9M | 44.4M | 49.0M | 29.5M | |
Tax Provision | 17.3K | 182.8K | 377.5K | 114.0K | 775.1K | 0.0 | |
Net Interest Income | (1.7M) | (2.7M) | (3.5M) | (3.7M) | (203.6K) | (213.8K) |
Cosmos Health Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Capital Expenditures | 672.8K | 117.7K | 890.5K | 383.1K | 9.2M | 9.6M | |
Net Income | (3.3M) | 820.8K | (8.0M) | (13.8M) | (18.5M) | (17.6M) | |
Change In Cash | (825.8K) | 589.9K | (341.9K) | 20.5M | (16.9M) | (16.1M) | |
Free Cash Flow | (5.5M) | (11.6M) | (8.0M) | (15.3M) | (24.8M) | (23.6M) | |
Other Non Cash Items | 1.7M | 236.3K | 1.5M | 6.7M | (975.7K) | (927.0K) | |
End Period Cash Flow | 38.5K | 628.4K | 286.5K | 20.7M | 3.8M | 2.3M | |
Change To Inventory | (271.5K) | 393.2K | (89.6K) | (485.5K) | (890.9K) | (846.4K) | |
Net Borrowings | 2.1M | 4.4M | 12.7M | 7.4M | 8.5M | 4.9M | |
Depreciation | 394.6K | 397.6K | 449.7K | 188.9K | 614.4K | 645.1K | |
Change To Netincome | 1.1M | 1.4M | (879.7K) | 6.0M | 6.9M | 7.2M |
Cosmos Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cosmos Health's current stock value. Our valuation model uses many indicators to compare Cosmos Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cosmos Health competition to find correlations between indicators driving Cosmos Health's intrinsic value. More Info.Cosmos Health is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Cosmos Health's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Cosmos Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Cosmos Health Systematic Risk
Cosmos Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cosmos Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Cosmos Health correlated with the market. If Beta is less than 0 Cosmos Health generally moves in the opposite direction as compared to the market. If Cosmos Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cosmos Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cosmos Health is generally in the same direction as the market. If Beta > 1 Cosmos Health moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Cosmos Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cosmos Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cosmos Health growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Cosmos Health November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cosmos Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cosmos Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cosmos Health based on widely used predictive technical indicators. In general, we focus on analyzing Cosmos Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cosmos Health's daily price indicators and compare them against related drivers.
Information Ratio | (0.12) | |||
Maximum Drawdown | 27.64 | |||
Value At Risk | (7.89) | |||
Potential Upside | 6.85 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.45) | Revenue Per Share 3.733 | Quarterly Revenue Growth 0.068 | Return On Assets (0.20) | Return On Equity (0.57) |
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cosmos Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.